Oppenheimer Maintains Outperform on Transcat, Raises Price Target to $160
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Martin Yang maintains an Outperform rating on Transcat (NASDAQ:TRNS) and raises the price target from $125 to $160.
May 22, 2024 | 4:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer analyst Martin Yang maintains an Outperform rating on Transcat and raises the price target from $125 to $160.
The raised price target from $125 to $160 and the maintained Outperform rating by Oppenheimer is a positive signal for investors, likely leading to increased investor confidence and a potential short-term price increase for TRNS.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100